Home › Malattie cardiovascolari › Tennessee › Nashville
Studi clinici su Malattie cardiovascolari a Nashville, TN
18 studi su Malattie cardiovascolari cercano partecipanti presso sedi a Nashville e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
In reclutamentoFase 4
- TriStar Centennial Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
In reclutamento
- Saint Thomas Research Institute, Nashville
Improving Veteran Referral to Cardiac Rehabilitation
In reclutamento
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Product Surveillance Registry
In reclutamentoStudio osservazionale
- Nashville, Nashville
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
In reclutamento
- Vanderbilt University Medical Center, Nashville
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
In reclutamentoFase 3
- Vanderbilt Univ Medi Cen, Nashville
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
In reclutamento
- Vanderbilt University Medical Center, Nashville
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
In reclutamentoFase 4Volontari sani benvenuti
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
In reclutamentoFase 2
- Vanderbilt University Medical Center, Nashville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
In reclutamentoFase 3
- Research Site, Nashville
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
In reclutamentoFase 3
- Ascension Saint Thomas, Nashville
Global Paradise System US Post Approval Study
In reclutamentoStudio osservazionale
- Ascension Saint Thomas, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
In reclutamento
- Vanderbilt, Nashville
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
In reclutamentoFase 2
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
In reclutamento
- Centennial Medical Center, Nashville
Randomized Trial of SGLT2i in Heart Transplant Recipients
In reclutamentoFase 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Gut Microbiota in Metabolic Surgery
In reclutamentoStudio osservazionale
- Vanderbilt_University MC, Nashville
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
In reclutamento
- Centennial Medical Center, Nashville
Studi su Malattie cardiovascolari in altre città
- Boston, MA37 studi
- New York City, NY33 studi
- Washington, DC28 studi
- Houston, TX24 studi
- Dallas, TX23 studi
- Atlanta, GA22 studi
- Cleveland, OH22 studi
- Chicago, IL21 studi
- Philadelphia, PA21 studi
- Pittsburgh, PA20 studi
- St. Louis, MO20 studi
- Los Angeles, CA18 studi
Altri studi a Nashville
- Cancro del polmone non a piccole cellule97 studi
- Cancro al seno81 studi
- Cancro metastatico70 studi
- Cancro colorettale69 studi
- Cancro (tutti i tipi)65 studi
- Cancro ovarico49 studi
- Cancro alla prostata43 studi
- Cancro ai polmoni40 studi
- Carcinoma a cellule squamose della testa e del collo39 studi
- Cancro pancreatico39 studi
- Cancro dell'endometrio38 studi
- Melanoma33 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.